Yüklüyor......
Systemic Sclerosis Trial Design Moving Forward
The 2013 ACR–EULAR classification criteria for systemic sclerosis (SSc) have shifted the construct of SSc. The new reality is that patients recruited for trials may not be so severe and not so advanced. We can now look for therapeutics that might stop disease evolution and/or prevent organ involveme...
Kaydedildi:
| Yayımlandı: | J Scleroderma Relat Disord |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5826575/ https://ncbi.nlm.nih.gov/pubmed/29492470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5301/jsrd.5000198 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|